CRISPR screening reveals ZNF217 as a vulnerability in high-risk B-cell acute lymphoblastic leukemia is a research paper published in Theranostics (2025). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5R01CA243386-02
Targeting FTO to treat acute myeloid leukemia
National Institutes of Health
Grant: 5R01CA280389-02
TET2-mediated epitranscriptomic regulation in leukemia microenvironment
National Institutes of Health
Grant: 5R37CA292678-02
The role, mechanism, and therapeutic potential of METTL1 in acute myeloid leukemia
National Institutes of Health
Grant: 1R01DK124116-01
The function and underlying mechanism of TET1 in myelodysplastic syndromes
National Institutes of Health
Grant: 5R01CA236399-02
The role and mechanism of METTL3/METTL14-mediated RNA modification in the pathogenesis and drug-resistance of AML
National Institutes of Health
Grant: 5R01CA271497-03
The role and therapeutic potential of IGF2BP2 in MLL-rearranged leukemia
Keywords